Fablyn

ATC：G03

治疗领域：Osteoporosis, Postmenopausal

药理分类：Sex hormones and modulators of the genital system

修订号：2 · 最新影响 PI 的程序：T/0003

适应症（原文）：Fablyn is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fracture. A significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated (see section 5.1). When determining the choice of Fablyn or other therapies, including oestrogens, for a postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefits (see section 5.1).